RecruitingNCT06458088
Advanced Glycation Products and Vascular Complications in Type 1 Diabetes
Advanced Glycation Products and the Incidence of Vascular Complications in Type 1 Diabetes: DIABAGE Study After More Than 5 Years
Sponsor
CHU de Reims
Enrollment
196 participants
Start Date
Jan 25, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
DIABAGE (Diabetes Advanced Glycation End products) study was conducted between 2015 and 2017. It included 196 type 1 diabetic patients with more than 10 years of diabetes. It revealed a significant association between the occurrence of vascular complications and tissular Advanced Glycation End products (AGEs) as well as with some circulating AGEs. This protocol is a continuation of that initial research.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Inclusion in initial DIABAGE study.
- Follow-up at Reims hospital.
Exclusion Criteria1
- \- Refusal to participate.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06458088
Related Trials
Genetics Of Autoimmunity In Type I Diabetes
NCT036489181 location
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
NCT052582921 location
Type 1 Diabetes Virtual Self-management Education and Support
NCT057568299 locations
Health Behavior Intervention for Adults With Type 1 Diabetes
NCT058231421 location
Exercise Training and Endothelial Function in Type 1 Diabetes
NCT035282261 location